IL22 and plasma cell myeloma: IL-22 acts on bone marrow stromal cells (BMSCs), which express IL-22RA1, leading to enhanced secretion of pro-survival and growth-promoting factors, such as IL-6 and VEGF, that support myeloma cell proliferation and survival.